NasdaqCM:AEHRSemiconductor
Aehr Test Systems (AEHR) Is Up 8.4% After Reinstating H2 Revenue Guidance Despite Weaker Q2 Results
In January 2026, Aehr Test Systems reported that its second-quarter fiscal 2026 sales fell to US$9.88 million, with a wider net loss of US$3.23 million compared with the prior year.
At the same time, the company reinstated revenue guidance of US$25 million to US$30 million for the second half of fiscal 2026, signaling renewed visibility into its near-term outlook.
Next, we’ll examine how the reinstated second-half revenue guidance shapes Aehr Test Systems’ investment narrative following...